Dr. Hemstreet as a clinician scientist obtained his Ph.D. following his medical training in Microbiology and Immunology. After completing his surgical residency his career developed as a clinical urologist and basic science researcher by utilizing his immunological background as it applied to tumor immunology and infectious disease and later to biophysical cytochemistry. Subsequently his career interests focused on the development of and validation of quantitative fluorescence image analysis for assaying proteins in single cells and more recently to the area of tissues proteomics (zeptomole level with a 15% variance). Early in his career he pioneered the field of molecular epidemiology and biomarkers when he scientific and medical director of Notification and Screening Program for workers exposed to aniline dyes sponsored by Workers Institute and NIOSH. This study contributed to defining the then new discipline of molecular epidemiology. The microscope based fluorescence technique used in this study was automated incorporating fluorescence imaging. This technology was later recognized by the National Research Council where Dr. Hemstreet served as Vice Committee for the committee on Biomarkers in Urinary Toxicology. The two year sojourn spawned the EDRN and served as a basis for increasing the funding for cancer prevention at the NCI. This leadership imitative was preceded by the programming of a fluorescence microscope for single cell proteomics. The sensitivity of this methodology defined alterations in nuclear and cytoplasmic actin depolymerization (G-actin/F-actin ratio) explaining the cardinal single cell signature of malignancy (nuclear cytoplasmic ratio). The instrumentation and the analysis of over 15,000 samples scientifically validated Slaughter”s hypothesis of molecular field disease in bladder cancer biopsy specimens which subsequently was further verified by a large bladder cancer six year longitudinal cohort study in five Chinese provinces. These concepts were vitally important for the integrated conceptual appreciation of biomarkers as it related to defining malignant associated dysplasia’s (Linxien Study) that heralded the malignant cancer phenotype. During these studies Dr. Hemstreet was the founder of a biomedical research company CytoDiagnostics which became the centerpiece and financial backbone for the establishment the Biomedical Research Park Associated with the University of Oklahoma Medical Center. The role of biomarkers for pharmacological monitoring of drug effects on cellular differentiation so key to chemoprevention was introduced. More recently, a method was developed for studying the proteomic changes in the human tissues microenvironment, a concept initially hypothesized in the National Research Council Report.
Teaching Interests
Urologic Oncology, Immunology, Biomarkers in Molecular Biology
Bladder Tumors Bishay John H., Park Eugene S., Hemstreet George P., Intravesical Immunotherapy: BCG [Book Chapter] 2011
Advances in Bladder Research Hurst Robert E., Waliszewski Przemyslaw, Waliszewska Miroslawa, Bonner Rebecca B., Benbrook Doris M., Dar Arindam, Hemstreet George P., Complexity, Retinoid-Responsive Gene Networks, and Bladder Carcinogenesis [Book Chapter] 1999
Hemstreet George P, Hurst Robert E, Bonner Rebecca B, Selection and Development of Biomarkers for Bladder Cancer - 3 [Book Chapter] 1998
Publications
The Prostate Zhou Cindy Ke, Stanczyk Frank Z., Hafi Muhannad, Veneroso Carmela C., Lynch Barlow, Falk Roni T., Niwa Shelley, Emanuel Eric, Gao Yu-Tang, Hemstreet George P., Zolfghari Ladan, Carroll Peter R., Manyak Michael J., Sesterhenn Isabell A., Levine Paul H., Hsing Ann W., Cook Michael B., Circulating and intraprostatic sex steroid hormonal profiles in relation to male pattern baldness and chest hair density among men diagnosed with localized prostate cancers 77:16, p. 1573 - 1582 2017
Cancer epidemiology, biomarkers & prevention Cook Michael B., Pfeiffer Ruth M., Hafi Muhannad, Niwa Shelley, Stanczyk Frank Z., Wood Shannon N., Veneroso Carmela C., Lynch Barlow, Emanuel Eric, Gao Yu-Tang, Falk Roni T., Zhou Cindy Ke, Manyak Michael J., Hemstreet George P., Zolfghari Ladan, Carroll Peter R., Sesterhann Isabell A., Levine Paul H., Hsing Ann W., Relationships between Circulating and Intraprostatic Sex Steroid Hormone Concentrations 26:11, p. 1660 - 1666 2017
Journal of the National Comprehensive Cancer Network Carroll Peter R., Parsons J. Kellogg, Andriole Gerald, Bahnson Robert R., Castle Erik P., Catalona William J., Dahl Douglas M., Davis John W., Epstein Jonathan I., Etzioni Ruth B., Farrington Thomas, Lange Paul H., Hemstreet George P., Kawachi Mark H., Kim Simon, Loughlin Kevin R., Lowrance William, Maroni Paul, Mohler James, Poch Michael, Morgan Todd M., Moses Kelvin A., Nadler Robert B., Scales Chuck, Shaneyfelt Terrence M., Smaldone Marc C., Sonn Geoffrey, Shead Dorothy A., Sprenkle Preston, Vickers Andrew J., Wake Robert, Freedman-Cass Deborah A., NCCN Guidelines Insights: Prostate Cancer Early Detection 14:5, p. 509 - 519 2016
Journal of the National Comprehensive Cancer Network Carroll Peter R., Sonn Geoffrey, Sprenke Preston, Freedman-Cass Deborah, Vickers Andrew J., Wake Robert, Shead Dorothy A., Bahnson Robert R., Parsons J. Kellogg, Andriole Gerald, Barocas Daniel A., Lange Paul H., Epstein Jonathan I., Etzioni Ruth B., Farrington Thomas, Hemstreet George P., Kawachi Mark H., Loughlin Kevin R., Davis John W., Castle Erik P., Catalona William J., Dahl Douglas M., Morgan Todd M., Lowrance William, Maroni Paul, Mohler James, Nadler Robert B., Poch Michael, Scales Chuck, Shaneyfelt Terrence M., Smaldone Marc C., Prostate Cancer Early Detection, Version 2.2015 Clinical Practice Guidelines in Oncology 13:12, p. 1534 - 1561 2015
Journal of the National Comprehensive Cancer Network Carroll Peter R., Parsons J. Kellogg, Andriole Gerald, Bahnson Robert R., Barocas Daniel A., Catalona William J., Dahl Douglas M., Davis John W., Epstein Jonathan I., Etzioni Ruth B., Giri Veda N., Hemstreet George P., Lowrance William, Kawachi Mark H., Lange Paul H., Loughlin Kevin R., Maroni Paul, Mohler James, Scales Chuck, Morgan Todd M., Nadler Robert B., Poch Michael, Shanefelt Terrence M., Vickers Andrew J., Ho Maria, Wake Robert, Shead Dorothy A., Prostate Cancer Early Detection, Version 1.2014 12:9, p. 1211 - 1219 2014
Journal of clinical oncology Tandra Pavankumar, Wang Jue, Loberiza Fausto R., Hemstreet George P., Krishnamurthy Jairam, Bhatt Vijaya Raj, Sarcomatoid renal cell carcinoma (SRCC): University of Nebraska Medical Center experience 31:6_suppl, p. 472 - 472 2013
Journal of immunotherapy (1997) Hemstreet George P., Rossi Gabriela R., Pisarev Vladimir M., Vahanian Nicholas N., Link Charles J., Enke Charles A., Helfner Laura, Hauke Ralph J., Tennant Lucinda, Ramsey William Jay, Cellular Immunotherapy Study of Prostate Cancer Patients and Resulting IgG Responses to Peptide Epitopes Predicted From Prostate Tumor-associated Autoantigens 36:1, p. 57 - 65 2013
Lasers in medical science Kaushik Dharam, Teply Benjamin A., Hemstreet George P., Novel treatment strategy for refractory hemorrhagic cystitis following radiation treatment of genitourinary cancer 27:5, p. 1099 - 1102 2012
Urology (Ridgewood, N.J.) Berglund Ryan K., Tangen Catherine M., Powell Isaac J., Lowe Bruce A., Haas Gabriel P., Carroll Peter R., Canby-Hagino Edith D., deVere White Ralph, Hemstreet George P., Crawford E. David, Thompson Ian M., Klein Eric A., Ten-year Follow-up of Neoadjuvant Therapy with Goserelin Acetate and Flutamide Before Radical Prostatectomy for Clinical T3 and T4 Prostate Cancer: Update on Southwest Oncology Group Study 9109 79:3, p. 633 - 637 2012
Prostate cancer Wang Jue, Wang Fen Wei, Hemstreet George P., Younger Age Is an Independent Predictor for Poor Survival in Patients with Signet Ring Prostate Carcinoma 2011, p. 216169 - 8 2011
Studies in health technology and informatics Park Eugene S, Boedeker Ben H, Hemstreet Jennifer L, Hemstreet George P, The initiation of a preoperative and postoperative telemedicine urology clinic 163, p. 425 - 427 2011
International braz j urol : official journal of the Brazilian Society of Urology Villanueva Carlos, Hemstreet George P, The approach to the difficult urethral catheterization among urology residents in the United States 36:6, p. 710 - 5; discussion 715-7 2010
Rare tumors Wang Jue, Wang Fen Wei, LaGrange Chad A, Hemstreet George P, Clinical features and outcomes of 25 patients with primary adenosquamous cell carcinoma of the prostate 2:3, p. 130 - 134 2010
Journal of the National Comprehensive Cancer Network Kawachi Mark H, Loughlin Kevin R, Mohler James, Moul Judd, Epstein Jonathan I, Etzioni Ruth B, Giri Veda N, Hemstreet George P, Howe Richard J, Lange Paul H, Lilja Hans, Nadler Robert B, Patterson Stephen G, Presti Joseph C, Stroup Antoinette M, Wake Robert, Wei John T, Carter H Ballentine, Bahnson Robert R, Barry Michael, Busby J Erik, Carroll Peter R, Catalona William J, Cookson Michael S, NCCN clinical practice guidelines in oncology: prostate cancer early detection 8:2, p. 240 - 262 2010
Sarcoma Wang Fen Wei, LaGrange Chad A., Hemstreet III, G., Kessinger Anne, Clinical Features of Sarcomatoid Carcinoma (Carcinosarcoma) of the Urinary Bladder: Analysis of 221 Cases, p. 1 - 7 2010
The Journal of urology Hemstreet George P., Editorial Comment 181:2, p. 553 - 553 2009
International journal of cancer Huang DALI, Casale George P, Tian JUN, Lele Subodh M, Pisarev Vladimir M, Simpson Melanie A, Hemstreet George P, UDP-glucose dehydrogenase as a novel field-specific candidate biomarker of prostate cancer 126:2, p. 315 - 327 2009
The Journal of urology Chen Chung-Hsin, Chiou Hung-Yi, Hsueh Yu-Mei, Chen Chien-Jen, YU Hong-Jeng, PU Yeong-Shiau, Hemstreet George P, Clinicopathological Characteristics and Survival Outcome of Arsenic Related Bladder Cancer in Taiwan. Commentary 181:2, p. 547 - 553 2009
International braz j urol : official journal of the Brazilian Society of Urology Villanueva Carlos, Hemstreet George P, Difficult male urethral catheterization: a review of different approaches 34:4, p. 401 - 11; discussion 412 2008
The Journal of urology Pisarev Vladimir M, Pickering Laura, Vahanian Nick, Rossi Gabriela, Ramsey Jay, Hauke Ralph, Tennant Lucinda, Enke Charles, Hemstreet George P, Link Charles J, VACCINATION OF PROSTATE CANCER PATIENTS WITH GENETICALLY MODIFIED ALLOGENEIC TUMOR CELL VACCINE INDUCES IgG RESPONSES TOWARD MULTIPLE PEPTIDE EPITOPES PREDICTED FROM COMMON PROSTATE TUMOR- ASSOCIATED AUTOANTIGENS 179:4S, p. 230 - 230 2008
Clinical cancer research Sabichi Anita L., Lerner Seth P., Atkinson E. Neely, Grossman H. Barton, Caraway Nancy P., Dinney Colin P., Penson David F., Matin Surena, Kamat Ashish, Brenner Dean E., Pisters Louis L., Lin Daniel W., Katz Ruth L., Hemstreet George P., Wargo Mary, Parnes Howard L., Bleyer Archie, Sanders William H., Clifford John L., Lippman Scott M., Phase III prevention trial of Fenretinide in patients with resected non-muscle-invasive bladder cancer 14:1, p. 224 - 229 2008
International journal of cancer Carreon Tania, Kadlubar Fred F., Ruder Avima M., Schulte Paul A., Hayes Richard B., Waters Martha, Grant Delores J., Boissy Robert, Beii Douglas A., Hemstreet George P., Yin Songnian, LeMasterS Grace K., Rothman Nathaniel, 'N-Acetyltransferases and the susceptibility to benzidine-induced bladder carcinogenesis' - Reply 121:7, p. 1637 - 1639 2007
Cancer epidemiology, biomarkers & prevention Huang DALI, Casale George P, Tian JUN, Wehbi Nizar K, Abrahams Neil A, Kaleem Zahid, Smith Lynette M, Johansson Sonny L, Elkahwaji Johny E, Hemstreet George P, Quantitative fluorescence imaging analysis for cancer biomarker discovery : Application to β-catenin in archived prostate specimens 16:7, p. 1371 - 1381 2007
The Journal of urology Hemstreet George P., Elkahwaji Johny E., Johansson Sonny, Huang Dali, Casale George P., Tian Jun, Wehbi Nizar K., Abrahams Neil A., Kaleem Zahid, Smith Lynette M., 1717: Quantitative Fluorescence Imaging Analysis for Cancer Biomarker Discovery: Application to B-Catenin in Archived Prostate Specimens 177:4S, p. 571 - 571 2007
Urology (Ridgewood, N.J.) Habuchi Tomonori, Marberger Michael, Schalken Jack A., Droller Michael J., Hemstreet George P., Grossman H. Barton, Schmitz-Dräger Bernd J., Murphy William M., Hautmann Stefan H., Bono Aldo V., Goebell Peter, Getzenberg Robert H., Messing Edward, Fradet Yves, Lokeshwar Vinata B., Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers 66:6, p. 64 - 74 2005
Urologic oncology Lewis Tamra E, Milam Terry D, Klingler Douglas W, Rao Prema S, Jaggi Meena, Smith David J, Hemstreet George P, Balaji K. C, Tissue transglutaminase interacts with protein kinase A anchor protein 13 in prostate cancer 23:6, p. 407 - 412 2005
Journal of clinical oncology Hemstreet G. P., Wehbi N. K., Casale G. P., Huang D., Tian J., Hutchinson L. M., Fluorescence imaging proteometry of thymosin β4 in single cells for detection of bladder transitional cell carcinoma 23:16_suppl, p. 4745 - 4745 2005
Urology (Ridgewood, N.J.) Klingler Douglas W, Hemstreet George P, Balaji K. C, Feasibility of robotic radical nephrectomy-initial results of single-institution pilot study 65:6, p. 1086 - 1089 2005
The Journal of urology Lerner Seth P., Sabichi Anita L., Grossman H. Barton, Penson David F., Dinney Colin P.N., Hemstreet George, Atkinson Edward N., Katz Ruth, Lippman Scott M., 913: Results of a Randomized Chemoprevention Trial with Fenretinide in Non-Muscle Invasive Bladder Cancer 173:4S, p. 246 - 247 2005
Cancer research (Chicago, Ill.) Jaggi Meena, Smith David J., Wheelock Margaret J., Johnson Keith R., Hemstreet George P., Rao Prema S., Balaji K.C., E-Cadherin Phosphorylation by Protein Kinase D1/Protein Kinase Cμ is Associated with Altered Cellular Aggregation and Motility in Prostate Cancer 65:2, p. 483 - 492 2005
Urology (Ridgewood, N.J.) Lokeshwar Vinata B, Habuchi Tomonori, Schalken Jack A, Fradet Yves, Marberger Michael, Messing Edward, Droller Michael J, Grossman H. Barton, Murphy William M, Hautmann Stefan H, Hemstreet George P, Bono Aldo V, Getzenberg Robert H, Goebell Peter, SCHMITZ-DRÄGER Bernd J, Bladder tumor markers beyond cytology : International consensus panel on bladder tumor markers 66:6A, p. 35 - 63 2005
Frontiers in bioscience Hemstreet George P, Wang Wenyu, Genotypic and phenotypic biomarker profiles for individual risk assessment and cancer detection (lessons from bladder cancer risk assessment in symptomatic patients and workers exposed to benzidine) 9:1-3, p. 2671 - 2679 2004
Internal medicine news (Short Hills, N.J. 1995) Hemstreet George P, Is robotic-assisted surgery clearly superior for radical prostatectomy for prostate cancer? 37:12, p. 12 2004
Urology Balaji K. C., Yohannes Paulos, Hemstreet G. P., McBride C. L., Oleynikov D., Feasibility of robot-assisted totally intracorporeal laparoscopic ileal conduit urinary diversion: Initial results of a single institutional pilot study 63:1, p. 51 - 55 2004
European urology supplements : official journal of the European Association of Urology Hemstreet George P, Omaha N.E, Biomarker profiles for individual risk assessment and prostate cancer prevention 2:6, p. 177 - 177 2003
Anticancer research Hurst Robert E., Kyker Kimberly D., Bonner Rebecca B., Bowditch Ron D., Hemstreet George P., Matrix-dependent Plasticity of the Malignant Phenotype of Bladder Cancer Cells 23:4, p. 3119 - 3128 2003
The Journal of urology Wehbi Nizar K, Bonner Rebecca B, Pitha Jan V, Hurst Robert E, Hemstreet George P, Dugger Ashley L, Pan-cadherin as a high level phenotypic biomarker for prostate cancer 167:5, p. 2215 - 2221 2002
BioTechniques Rao Jian Yu, Seligson David, Hemstreet George P., Protein Expression Analysis Using Quantitative Fluorescence Image Analysis on Tissue Microarray Slides 32:4, p. 924 - 932 2002
JNCI : Journal of the National Cancer Institute Hemstreet George, RESPONSE: Re: Biomarker Risk Assessment and Bladder Cancer Detection in a Cohort Exposed to Benzidine 93:19, p. 1492a - 1493 2001
JNCI : Journal of the National Cancer Institute Hemstreet George P., Yin Songnian, Ma Zhenzhong, Bonner Rebecca Bass, Bi Wenfang, Rao Jian Y., Zang Meifu, Zheng Qinlong, Bane Barbara, Asal Nabih, Wang Wenyu, Li Guilan, Feng Peiwen, Hurst Robert E., Biomarker Risk Assessment and Bladder Cancer Detection in a Cohort Exposed to Benzidine 93:6, p. 427 - 436 2001
Cancer Birckbichler Paul J., Bonner Rebecca B., Hurst Robert E., Bane Barbara L., Pitha Jan V., Hemstreet George P., Loss of tissue transglutaminase as a biomarker for prostate adenocarcinoma 89:2, p. 412 - 423 2000
Cancer detection and prevention Hemstreet G P, Bell D, Bane B L, Bonner R B, Hurst R E, Abnormal G-actin content in single prostate cells as a biomarker of prostate cancer 24:5, p. 464 - 472 2000
The Journal of urology Lianes P., Charytonowicz E., Cordon-Cardo C., Fradet Y., Grossman H.B., Chew K., Wheeless L.L., Faraggi D., Hemstreet G.P., Waldman F.M., Biomarker Study of Primary Nonmetastatic Versus Metastatic Invasive Bladder Cancer 161:5, p. 1716 - 1717 1999
The Journal of urology Birckbichler Paul J., Kong Jin, Laszik Zoltan G., Bonner Rebecca B., Hurst Robert E., Hemstreet George P., EXPRESSION OF TISSUE TRANSGLUTAMINASE IN HUMAN DIABETIC KIDNEY TISSUE SECTIONS, p. 84 1999
The Journal of urology Hemstreet George P., Bonner Rebecca B., Kong Jin, Asal Nabih, Hurst Robert E., BIOMARKERS IN THE PREMALIGNANT FIELD PREDICT INDIVIDUAL CANCER RISK, p. 153 1999
The Journal of urology Hemstreet George P., EXPRESSION AND PROGNOSTIC VALUE OF CD44 ISOFORMS IN TRANSITIONAL CELL CARCINOMA OF RENAL PELVIS AND URETER, p. 808 - 809 1999
Molecular and cellular endocrinology Waliszewski Przemyslaw, Waliszewska Miroslawa, Gordon Niquel, Hurst Robert E., Benbrook Doris M., Dhar Arindam, Hemstreet George P., Retinoid signaling in immortalized and carcinoma-derived human uroepithelial cells 148:1, p. 55 - 65 1999
Urologic oncology Waliszewski Przemyslaw, Hemstreet George P., Waliszewska Miroslawa K., Hurst Robert E., Expression of sex steroid receptor genes and comodulation with retinoid signaling in normal human uroepithelial cells and bladder cancer cell lines 3:5, p. 141 - 147 1997
Seminars in oncology Bane B L, Rao J Y, Hemstreet G P, Pathology and staging of bladder cancer 23:5, p. 546 - 570 1996
The Journal of urology Mora L. B, Nicosia S. V, POW-SANG J. M, KU N. K, Einstein A, Hemstreet G. P, Diaz J. I, Lockhart J, Ancillary techniques in the followup of transitional cell carcinoma : A comparison of cytology, histology and deoxyribonucleic acid image analysis cytometry in 91 patients. Commentary 156:1, p. 49 - 55 1996
Journal of immunotherapy (1997) Whitehead Robert P., Solanki Dilip L., Wolf Michael K., Hemstreet George P., Benedetto Pasquale, Richman Stephen P., Flanigan Robert C., Crawford E. David, A Phase II Trial of Continuous-Infusion Recombinant Interleukin-2 in Patients with Advanced Renal Cell Carcinoma 18:2, p. 104 - 114 1995
Environmental and molecular mutagenesis Kusser Wolfgang C., Miao Xili, Glickman Barry W., Friedland Joan M., Rothman Nathaniel, Hemstreet George P., Mellot John, Swan David C., Hayes Richard B., Schulte Paul A., p53 mutations in human bladder cancer 24:3, p. 156 - 160 1994
Cancer Bonner Rebecca B., Rao Jian Yu, Hemstreet George P., Fradet Yves, Min Kyung Whan, Hurst Robert E., Bladder cancer risk assessment with quantitative fluorescence image analysis of tumor markers in exfoliated bladder cells 72:8, p. 2461 - 2469 1993
Proceedings of the National Academy of Sciences - PNAS Rao Jian Yu, Bonner Rebecca Bass, Jones Philip L., Min Kyung Whan, Fradet Yves, Hurst Robert E., Hemstreet George P., Alterations in Phenotypic Biochemical Markers in Bladder Epithelium During Tumorigenesis 90:17, p. 8287 - 8291 1993
The Journal of urology Kuebler J. Philip, Whitehead Robert P., Ward David L., Hemstreet George P., Bradley Edward C., Treatment of Metastatic Renal Cell Carcinoma with Recombinant Interleukin-2 in Combination with Vinblastine or Lymphokine-Activated Killer Cells 150:3, p. 814 - 820 1993
Journal of occupational medicine Bi WenFang, Rao Jian Yu, Hemstreet George P., Fang Peiwen, Asal Nabih R., Zang Meifu, Min Kyung W., Ma Zhengzhong, Lee Elisa, Li Guilian, Hurst Robert E., Bonner Rebecca B., Wang Yan, Fradet Yves, Yin Songnian, Field Molecular Epidemiology: Feasibility of Monitoring for the Malignant Bladder Cell Phenotype in a Benzidine-Exposed Occupational Cohort 35:1, p. 20 - 27 1993
The Journal of urology Hemstreet George P., Rollins Scott, Jones Philip, Rao Jian Yu, Hurst Robert E., Bonner Rebecca Bass, Smith Bobby G., Hewett Tommy, Identification of a High Risk Subgroup of Grade 1 Transitional Cell Carcinoma Using Image Analysis Based Deoxyribonucleic Acid Ploidy Analysis of Tumor Tissue 146:6, p. 1525 - 1529 1991
The Journal of urology Moon Timothy D., Harmon Edwin P., Bass Rebecca A., Colcolough Maureen, Hemstreet George P., Hurst Robert E., Quantitative Fluorescence Image Analysis of Deoxyribonucleic Acid Ploidy in Urine From Normal Children 145:6, p. 1236 - 1237 1991
Journal of occupational medicine Marsh Gary M., Callahan Catherine, Pavlock David, Leviton Laura C., Talbott Evelyn O., Hemstreet George, A Protocol for Bladder Cancer Screening and Medical Surveillance among High-Risk Groups: The Drake Health Registry Experience 32:9, p. 881 - 886 1990
Journal of occupational medicine Hemstreet George P., Hurst Robert E., Bass Rebecca A., Rao Jian Yu, Quantitative Fluorescence Image Analysis in Bladder Cancer Screening 32:9, p. 822 - 828 1990
The American journal of surgery McGowan Patrick F., Bass Rebecca A., Hemstreet George P., Lane Mary M., Zompa Edward, Murray Cynthia K., Postier Russell G., Hurst Robert E., Early detection of colorectal cancer by quantitative fluorescence image analysis of exfoliated cells 159:1, p. 172 - 177 1990
Hurst R. E, Jones P. L, Rao JIAN YU, Hemstreet G. P, Molecular and cellular biological approaches and techniques in the detection of bladder cancer and enhanced risk for bladder cancer in high-risk groups 1990
International journal of cancer Hemstreet George P., Schulte Paul A., Ringen Knut, Stringer William, Altekruse Ernest B., DNA hyperploidy as a marker for biological response to bladder carcinogen exposure 42:6, p. 817 - 820 1988
The Journal of urology Parry William L., Hemstreet George P., Cancer Detection by Quantitative Fluorescence Image Analysis 139:2, p. 270 - 274 1988
Toxicology and industrial health Pitha Jan V., Hemstreet George P., Silva Fred G., Asal Nabih R., Petrone Robert L., Trump Benjamin F., Occupational Hydrocarbon Exposure and Renal Histopathology 3:4, p. 491 - 506 1987
International journal of cancer Bass Rebecca A., Hemstreet George P., Honker Nancy A., Hurst Robert E., Doggett Reuben S., DNA cytometry and cytology by quantitative fluorescence image analysis in symptomatic bladder cancer patients 40:5, p. 698 - 705 1987
Gynecologic oncology Smith Jeffrey J., Cowan Linda, Hemstreet George, McGill Linda, Smith McClure L., Pippitt Charles H., Doggett Rueben, Automated quantitative fluorescent image analysis of cervical cytology 28:3, p. 241 - 254 1987
The Journal of urology Hemstreet George P., Bass Rebecca A., Hurst Robert E., Jones Phil L., Doggett Reuben S., Schulte Paul A., Ringen Knut, Witherington Roy, 452 - Qfia in Defining Bladder Cancer Risk in High-Risk Cohorts and Management of Symptomatic Bladder Cancer Patients 137:6, p. 216A - 216A 1987
The Journal of urology Hemstreet George P., Whitehead Robert P., Owen-Schaub Laurie B., DeBault Lawrence E., 475 - Interleukin 2 (IL-2) in the Management of Patients with Renal Cell Carcinoma 137:6, p. 222A - 222A 1987
Chest Gasbarra D., Bass B., Levin D., Honker N., Hemstreet G., Automated Identification of Aneuploid Cells in Lung Cancer 91:3, p. 3s - 4s 1987
Cancer Schulte Paul A., Gullen Warren H., Ringen Knut, Hemstreet George P., Altekruse Ernest B., Tillett Sandra, Allsbrook William C., Crosby John H., Witherington Roy, Stringer William, Brubaker Margaret M., Risk factors for bladder cancer in a cohort exposed to aromatic amines 58:9, p. 2156 - 2162 1986
Journal of occupational medicine Schulte Paul A., Ringen Knut, Hemstreet George P., Optimal Management of Asymptomatic Workers at High Risk of Bladder Cancer 28:1, p. 13 - 17 1986
International journal of cancer Hemstreet George P., West Seymour S., Weems W. Lamar, Echols Candace K., Lindseth Gunnbjorg, McFarland Sandra, Lewin Jack, Quantitative fluorescence measurements of ao‐stained normal and malignant bladder cells 31:5, p. 577 - 585 1983
The Journal of urology Smalley R.V., Bartolucci A.A., Hester M., Hemstreet G., A Phase II Evaluation of a 3-Drug Combination of Cyclophosphamide, Doxorubicin and 5-Fluorouracil and of 5-Fluorouracil in Patients with Advanced Bladder Carcinoma or Stage D Prostatic Carcinoma 125:2, p. 191 - 195 1981
International journal of cancer Hemstreet George P., Wittliff James L., Sarrif Awni M., Hall Miles L., McRae Lillian J., Durant John R., Comparison of steroid receptor levels in renal‐cell carcinoma and autologous normal kidney 26:6, p. 769 - 775 1980
Urology (Ridgewood, N.J.) Griggs W.Phillips, Hemstreet George P., Pathologic and immunologic considerations in malakoplakia 16:6, p. 638 - 645 1980
Urology (Ridgewood, N.J.) Older Robert A., Hemstreet George P., Jackson Donald C., Johnsrude Irwin S., Suspicious appearance of simple cyst caused by technical artifact 9:4, p. 466 - 468 1977
Urology (Ridgewood, N.J.) Sink James D., Everett Anderson E., Hemstreet George P., Technique to assure urinary drainage through nephrostoiviy tube 9:2, p. 185 - 185 1977